The browser version you are using is not recommended for this site.Please consider upgrading to the latest version of your browser by clicking one of the following links.
We are sorry, This PDF is available in download format only
Intel® Xeon® Processor E3-1200 Product Family BriefServers based on the Intel® Xeon® processor E3-1200 product family give you smarter control of the things that matter to your businessIn an on-demand world, businesses of every size must be responsive. So ask yourself: Can you and your employees access the programs and files you need – anywhere and at any time? Can you expand your IT systems simply and cost-effectively to support more users, new applications, and growing storage needs? Is your business protected against catastrophic data loss and security breaches? If not, it’s time to consider stepping up to a real server.Servers based on the Intel® Xeon® processor E3-1200 product family can help small businesses improve responsiveness and expand capabilities so they can compete more effectively in today’s accelerated business world. Based on 32nm Intel® microarchitecture, the Intel Xeon processor E3-1200 product family is designed with innovative features that adapt server performance to the needs of your business, so you enjoy faster application response times with reduced energy consumption. Intel Xeon processor E3-1200 product family-based servers also protect your valuable data against loss or corruption – a critical advantage given that 75 percent of small businesses experienced two or more cyber attacks in the twelve-month period ending in May of 2010, 1 and 50 percent of small businesses have lost critical data within the last year.Servers featuring the Intel Xeon processor E3-1200 product family are ideal for small businesses stepping up to their first server, companies requiring a dedicated server for a workgroup, and organizations that need a server to support multiple clients.Read the full Intel® Xeon® Processor E3-1200 Product Family Brief.
Touch-based apps for Ultrabooks™ spur pharmaceutical research productivity and IT compatibility.